79 related articles for article (PubMed ID: 3509385)
1. 1-Chloropiperazinic derivative (ER 311) of norfloxacin: antibacterial activity in vitro and pharmacokinetic properties in mice.
Dubini F; Balsari A; Stradi R; Riviera L
Chemioterapia; 1987 Jun; 6(2 Suppl):178-80. PubMed ID: 3509385
[No Abstract] [Full Text] [Related]
2. Antibacterial activity and pharmacokinetics in mice of two new derivatives of norfloxacin.
Balsari A; Dubini F; Stradi R; Riviera L
Chemioterapia; 1987 Jun; 6(2 Suppl):176-8. PubMed ID: 3509384
[No Abstract] [Full Text] [Related]
3. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
4. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of cefatrizine on clinical isolates of gram-positive, gram-negative cocci, Haemophilus, and Enterobacteriaceae.
Boisivon A; Perenet F; Guiomar C
J Chemother; 1989 Jul; 1(4 Suppl):304-5. PubMed ID: 16312412
[No Abstract] [Full Text] [Related]
6. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
7. [In vitro fluoroquinolone resistance in ocular bacterial isolates].
Sun XG; Wang ZQ; Li R; Chen L; Jin XY; Luo SY
Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections].
Mróz E; Jankowski S; Bartelmus J; Grzybek-Hryncewicz K; Ruczkowska J; Starek J; Boratyńska M
Med Dosw Mikrobiol; 1993; 45(1):115-8. PubMed ID: 8231429
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
[No Abstract] [Full Text] [Related]
10. Preliminary results on the antibacterial and killing activity of lomefloxacin.
Stefani S; Pellegrino MB; Mezzatesta M; Speciale AM; Caccamo F; Russo G; Nicoletti G
J Chemother; 1989 Jul; 1(4 Suppl):170-2. PubMed ID: 16312355
[No Abstract] [Full Text] [Related]
11. Testing of microbial sensitivity to cephalosporin.
Dorobăţ O; Bărbulescu C; Păun L
Arch Roum Pathol Exp Microbiol; 1989; 48(2):185-8. PubMed ID: 2634370
[No Abstract] [Full Text] [Related]
12. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of clinical isolates of gram-positive and gram-negative organisms to cefatrizine.
Carlone NA; Cuffini AM; Forno Pizzoglio M; Cavallo G
Drugs Exp Clin Res; 1985; 11(7):447-51. PubMed ID: 3836867
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002.
Bouchillon SK; Hoban DJ; Johnson BM; Stevens TM; Dowzicky MJ; Wu DH; Bradford PA
Diagn Microbiol Infect Dis; 2005 Apr; 51(4):291-5. PubMed ID: 15808321
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
Cuffini AM; Tullio V; Vaiani G; Carlone NA
J Chemother; 1989 Jul; 1(4 Suppl):178-81. PubMed ID: 16312358
[No Abstract] [Full Text] [Related]
16. Preliminary results on the antibacterial activity of sagamicin towards microorganisms responsible for ocular pathology.
Mezzatesta ML; Pellegrino MB; D'Amico G; Uva M; Russo G; Nicoletti G
J Chemother; 1989 Jul; 1(4 Suppl):191-2. PubMed ID: 16312363
[No Abstract] [Full Text] [Related]
17. Synthesis and antibacterial activity of some 5-(4-biphenylyl)-7-aryl[3,4-d] [1,2,3]-benzothiadiazoles.
Balasankar T; Gopalakrishnan M; Nagarajan S
Eur J Med Chem; 2005 Jul; 40(7):728-31. PubMed ID: 15935906
[TBL] [Abstract][Full Text] [Related]
18. Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.
Barry AL; Jones RN
Pediatr Infect Dis J; 1987 Oct; 6(10):954-7. PubMed ID: 3696835
[TBL] [Abstract][Full Text] [Related]
19. [Activity of norfloxacin against gram-negative bacteria].
Ben Redjeb S; Ennaifer M; Kechrid A; Ben Hassen A; Boujnah A
Tunis Med; 1989; 67(6-7):391-5. PubMed ID: 2508283
[No Abstract] [Full Text] [Related]
20. Antibacterial activity of Wratizolin.
Mulczyk M
Arch Immunol Ther Exp (Warsz); 1983; 31(5):611-3. PubMed ID: 6675569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
